DK1090915T3 - Polymorphic B form af 3-(cyclopropylmethoxy)-4--4-(methylsulfonyl)phenyl- 5,5-dimethyl-5H-furan-2-on - Google Patents

Polymorphic B form af 3-(cyclopropylmethoxy)-4--4-(methylsulfonyl)phenyl- 5,5-dimethyl-5H-furan-2-on

Info

Publication number
DK1090915T3
DK1090915T3 DK99402482T DK99402482T DK1090915T3 DK 1090915 T3 DK1090915 T3 DK 1090915T3 DK 99402482 T DK99402482 T DK 99402482T DK 99402482 T DK99402482 T DK 99402482T DK 1090915 T3 DK1090915 T3 DK 1090915T3
Authority
DK
Denmark
Prior art keywords
cyclopropylmethoxy
methylsulfonyl
polymorphic
dimethyl
furan
Prior art date
Application number
DK99402482T
Other languages
English (en)
Inventor
Beatrice Calais
Evelyne Chassagneux
Jean-Michel Bonard
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Sas filed Critical Merial Sas
Application granted granted Critical
Publication of DK1090915T3 publication Critical patent/DK1090915T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/60—Two oxygen atoms, e.g. succinic anhydride
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
DK99402482T 1999-10-08 1999-10-08 Polymorphic B form af 3-(cyclopropylmethoxy)-4--4-(methylsulfonyl)phenyl- 5,5-dimethyl-5H-furan-2-on DK1090915T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99402482A EP1090915B1 (en) 1999-10-08 1999-10-08 Polymorphic B form of 3-(cyclopropylmethoxy)-4-¬-4-(methylsulfonyl)phenyl - 5,5-dimethyl-5H-furan-2-one

Publications (1)

Publication Number Publication Date
DK1090915T3 true DK1090915T3 (da) 2009-07-13

Family

ID=8242136

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99402482T DK1090915T3 (da) 1999-10-08 1999-10-08 Polymorphic B form af 3-(cyclopropylmethoxy)-4--4-(methylsulfonyl)phenyl- 5,5-dimethyl-5H-furan-2-on

Country Status (12)

Country Link
US (1) US6677373B2 (da)
EP (1) EP1090915B1 (da)
JP (1) JP4805505B2 (da)
AT (1) ATE432269T1 (da)
AU (2) AU774172C (da)
CA (1) CA2386549C (da)
CY (1) CY1110062T1 (da)
DE (1) DE69940922D1 (da)
DK (1) DK1090915T3 (da)
ES (1) ES2326849T3 (da)
PT (1) PT1090915E (da)
WO (1) WO2001027097A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2417019T3 (es) 2003-11-13 2013-08-05 University Of Georgia Research Foundation, Inc. Procedimiento de caracterización del virus de la enfermedad de la bursitis infecciosa
US7151158B2 (en) * 2004-01-30 2006-12-19 General Electric Company Method of preparing a poly(arylene ether), apparatus therefor, and poly(arylene ether) prepared thereby
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
UA57002C2 (uk) * 1995-10-13 2003-06-16 Мерк Фросст Кенада Енд Ко./Мерк Фросст Кенада Енд Сі. Похідне (метилсульфоніл)феніл-2-(5н)-фуранону, фармацевтична композиція та спосіб лікування
EP0904269B1 (en) * 1995-10-30 2002-01-23 Merck Frosst Canada & Co. 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
DE69702182T2 (de) * 1996-02-01 2001-03-01 Merck Frosst Canada Inc Alkylierte styrole als prodrugs zu cox-2-inhibitoren
JP2001514668A (ja) * 1997-03-14 2001-09-11 メルク フロスト カナダ アンド カンパニー Ｃｏｘ−２阻害薬としての酸素連結部を有する（メチルスルホニル）フェニル−２−（５ｈ）−フラノン類

Also Published As

Publication number Publication date
JP4805505B2 (ja) 2011-11-02
US20030050337A1 (en) 2003-03-13
WO2001027097A1 (en) 2001-04-19
CY1110062T1 (el) 2015-01-14
PT1090915E (pt) 2009-08-03
AU774172C (en) 2005-06-09
CA2386549C (en) 2010-09-21
EP1090915A1 (en) 2001-04-11
US6677373B2 (en) 2004-01-13
AU774172B2 (en) 2004-06-17
AU2004206979A1 (en) 2004-09-30
EP1090915B1 (en) 2009-05-27
ES2326849T3 (es) 2009-10-20
AU7921800A (en) 2001-04-23
JP2003511443A (ja) 2003-03-25
CA2386549A1 (en) 2001-04-19
ATE432269T1 (de) 2009-06-15
DE69940922D1 (de) 2009-07-09

Similar Documents

Publication Publication Date Title
MA27349A1 (fr) Composition cristalline renfermant de l'escitalopram.
ES2172864T3 (es) 2-metoxibenzofenonas fungicidas.
NO920767D0 (no) Pyranylcyanoguanidin-derivater
IL98378A0 (en) Substituted phthalides and heterocyclic phthalides,their preparation and their use as herbicides
AU8052901A (en) Methods of synthesizing an oxidant and applications thereof
FR2691468B1 (fr) 3-(Acyloxyphényl)benzofuran 2 ones comme stabilisants.
RS50071B (sr) Novi oblik soli pantoprazola
IL143868A (en) Use of 3 - (2,4,6 - trimethylphenyl)- 4 - neopentylcarbonyloxy- 5, 5 - tetramethylene -delta 3 - dihydrofuran -2 -one for controlling the white fly
CY1107913T1 (el) Πολυμορφικες και αλλες κρυσταλλικες μορφες cis-ftc
ATE237612T1 (de) Benzofuranderivate
DK1100789T3 (da) Substituerede benzoylcyclohexandioner
HRP20030853B1 (en) Crystalline form of omeprazole
KR950017992A (ko) 알프조신 염산염의 2수화물
CY1110062T1 (el) Πολυμορφικη μορφη β της 3-(κυκλοπροπυλμεθοξυ)4- [ -4-(μεθυλσουλφονυλ)φαινυλ]-5,5-διμεθυλ-5η-φουραν-2-ονης
BR0102430A (pt) Precursores de fragrância
DE60101639D1 (de) Ein (1'R,2'S,5'R)-3-l-Menthoxypropan-1-ol, das eine kühlende Empfindung erzeugt
HRP20021032B1 (en) NOVEL SOLID BODY FORMS OF MESOPROGESTIN 11C-[4E-(HYDROXYIMINOMETHYL)-PHENYL]-17α-METHOXYMETHYL-17C-METHOXY-ESTRA-4,9-DIEN-3-ONE
DE60006825D1 (de) Serotonerge benzofurane
ATE250021T1 (de) Hydroxycyclopentanone
JP2001354766A5 (da)
DK1240163T3 (da) 3-(4,5-Dihydroisoxazol-5-yl)-benzoylpyrazoler
ID27686A (id) Turunan 3-(2-okso-[1,3]bipirolidinil-3-ildenametil)-sefem
ATE469902T1 (de) Amorphe substanz eines tricyclischen triazolobenzazepinderivats
ATE282726T1 (de) Herstellung von verbindungen auf basis von cu-in- se phasengleichgewichten
ATE92479T1 (de) Neue 1,3-oxazine.